Predicted Trait | |
Reported Trait | Testicular cancer |
Mapped Trait(s) |
Score Construction | |
PGS Name | CC_Testis_IV |
Development Method | |
Name | 52 variants from Graff et al (PGS000086) with inverse variant weights |
Parameters | NR |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 52 |
Effect Weight Type | Inverse-variance weighting |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000186 |
Citation (link to publication) | Kachuri L et al. Nat Commun (2020) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 100% 56,799 individuals (100%) |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST004635 Europe PMC: 28604728 |
24,573 individuals | European | 6 cohorts
|
GWAS Catalog: GCST002022 Europe PMC: 23666240 |
5,932 individuals | European | B58C, UKBS, UKTCC |
GWAS Catalog: GCST004713 Europe PMC: 28604732 |
17,528 individuals | European | NCI, Penn, Sweden |
GWAS Catalog: GCST002023 Europe PMC: 23666239 |
1,638 individuals | European | FCCC, NCI, UPENN |
GWAS Catalog: GCST003246 Europe PMC: 26503584 |
5,932 individuals | European | B58C, UKBS, UKTCC |
GWAS Catalog: GCST000416 Europe PMC: 19483682 |
1,196 individuals | European | FCCC, PennCATH, UPENN |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM002067 | PSS001024| European Ancestry| 179,537 individuals |
PGP000186 | Kachuri L et al. Nat Commun (2020) |
Reported Trait: Incident testicular cancer | HR: 2.26 [1.71, 2.99] | AUROC: 0.787 C-index: 0.766 (0.033) |
R²: 0.605 | Age at assessment, genotyping array, PCs(1-15) | C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years. |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS001024 | Individuals with at least one recorded incident diagnosis of a borderline, in situ, or malignant primary cancer were defined as cases. | — | [ ,
100.0 % Male samples |
— | European | — | UKB | — |